The chimeric antigen receptor (CAR)-T cell therapy market is expected to witness market growth at a rate of 26.25% in the forecast period of 2021 to 2028. CAR-T cell therapy is a type of therapy in which T-cells which is taken from the patient’s blood are improved in the laboratory with the addition of a special protein receptor on the T-cells that attack cancer cells.